Clinical Trial

Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B

Enrolling by Invitation Phase 1/2
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the effect of allogeneic mesenchymal stem cell therapy on patients who suffered from liver cirrhosis caused by Hepatitis B.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-04-21; most recent amendment 2026-02-23.
Status change: Recruiting → Enrolling by Invitation 2026-02-23
Trial Details
NCT Number NCT04357600
Lead Sponsor PT. Prodia Stem Cell Indonesia
Conditions Liver Cirrhoses
Enrollment 12 participants
Start Date 2018-05-17
Primary Completion 2027-06-20 (estimated)
Study Completion 2028-12-20 (estimated)
Updated on ClinicalTrials.gov 2026-02-25